Dr. Multani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12526 High Bluff Drive
Suite 360
San Diego, CA 92130Phone+1 858-209-2053- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1998
- Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
- Massachusetts General HospitalInternship, Internal Medicine, 1993 - 1994
- Harvard Medical SchoolClass of 1993
Certifications & Licensure
- CA State Medical License 2001 - 2024
Publications & Presentations
PubMed
- 83 citationsA Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105, , , , , , , , , , , , , , , , , , , , , > ;Cancer Discovery. 2019 Mar 1
- 30 citationsALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.Kasey L. Couts, Judson Bemis, Jacqueline A. Turner, Stacey M. Bagby, Danielle Murphy, Jason Christiansen, Jennifer D. Hintzsche, Anh T. Le, Todd M. Pitts, Keith Wells,...> ;Molecular Cancer Therapeutics. 2018 Jan 1
- 17 citationsResponse to Entrectinib in Differentiated Thyroid Cancer With a ROS1 FusionStephen V. Liu, Laura Macke, Bradley S Colton, Sikandar S Imran, Jason Christiansen, Edna Chow-Maneval, Zachary Hornby, Pratik S. Multani> ;JCO Precision Oncology. 2017 Dec 8
- Join now to see all
Press Mentions
- Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus ChemotherapyOctober 25th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: